BTAIVSDNA• 3 Months (Normalized)
BTAI vs DNA (BioXcel Therapeutics Inc. vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Jun 30 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
DNA Performance $10.46
+5.55%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
-5.55 pts
DNA outperforming by 5.55 percentage points
BTAIDNA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | BTAI Price | BTAI Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 28, 2026 | $- | $10.46 | +5.55% | - | |
| Sep 25, 2026 | $- | $10.66 | +7.57% | - | |
| Sep 24, 2026 | $0.04 | -97.50% | $10.25 | +3.43% | -100.93% |
| Sep 23, 2026 | $0.05 | -96.81% | $8.58 | -13.42% | -83.39% |
| Sep 22, 2026 | $0.04 | -96.84% | $9.37 | -5.45% | -91.39% |
| Sep 21, 2026 | $0.06 | -95.64% | $7.98 | -19.48% | -76.16% |
| Sep 18, 2026 | $0.06 | -95.89% | $7.88 | -20.48% | -75.41% |
| Sep 17, 2026 | $0.08 | -94.67% | $7.84 | -20.89% | -73.78% |
| Sep 16, 2026 | $0.07 | -95.26% | $7.06 | -28.76% | -66.50% |
| Sep 15, 2026 | $0.04 | -96.83% | $6.99 | -29.47% | -67.36% |
| Sep 14, 2026 | $0.05 | -96.80% | $7.01 | -29.26% | -67.54% |
| Sep 11, 2026 | $0.05 | -96.38% | $6.75 | -31.89% | -64.49% |
| Sep 10, 2026 | $0.05 | -96.45% | $6.78 | -31.58% | -64.87% |
| Sep 09, 2026 | $0.05 | -96.67% | $6.79 | -31.48% | -65.19% |
| Sep 08, 2026 | $0.04 | -96.95% | $6.94 | -29.97% | -66.98% |
Page 1 of 5